| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Biomarin Pharmaceutical Inc.'s insiders have reduced their positions by a net 17,557 shares worth roughly $1.2M.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 214.6K | $11.95M | - | |
| CFO | 123.3K | $6.86M | - | |
| VP | 84.1K | $4.68M | - | |
| VP | 61.0K | $3.40M | - | |
| Dir | 49.4K | $2.75M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 17, 2020 | V Bryan Lawlis53 | Director | Sale+OE | 8,360 | $76.01 | $635,469.70 | -30.6% | |
| Mar 9, 2020 | Jean Jacques Bienaime68 | Chief Executive Officer | Sale+OE | 10,000 | $89.52 | $895,200.00 | -3.3% | |
| Feb 3, 2020 | Jean Jacques Bienaime68 | Chief Executive Officer | Sale+OE | 10,000 | $83.50 | $835,000.00 | -3.0% | |
| Jan 14, 2020 | Jean Jacques Bienaime68 | Chief Executive Officer | Sale+OE | 8,000 | $87.95 | $703,600.00 | -2.4% | |
| Jan 8, 2020 | Jean Jacques Bienaime68 | Chief Executive Officer | Sale+OE | 7,000 | $84.72 | $593,060.00 | -2.1% | |
| Dec 27, 2019 | Jean Jacques Bienaime68 | Chief Executive Officer | Sale+OE | 8,000 | $86.26 | $690,090.00 | -2.4% | |
| Dec 17, 2019 | V Bryan Lawlis53 | Director | Sale+OE | 3,750 | $83.36 | $312,600.00 | -13.7% | |
| Nov 26, 2019 | George Eric Davis65 | EVP, General Counsel | Sell | 3,190 | $79.66 | $254,115.40 | -4.4% | |
| Nov 22, 2019 | Jean Jacques Bienaime68 | Chief Executive Officer | Sale+OE | 10,000 | $77.60 | $776,000.00 | -3.0% | |
| Oct 25, 2019 | Jean Jacques Bienaime68 | Chief Executive Officer | Sale+OE | 5,000 | $69.55 | $347,750.00 | -1.5% |